MYC and colorectal carcinoma: Specifically, metabolic reprogramming in CRC is associated with aberrant c-Myc activation, which plays a pivotal role in manipulating 121 metabolic genes [53]; for example, it downregulates mitochondrial biogenesis genes but upregulates genes relating to DNA and histone modification.